206 related articles for article (PubMed ID: 36786081)
1. Management of patients with germline predisposition to haematological malignancies considered for allogeneic blood and marrow transplantation: Best practice consensus guidelines from the UK Cancer Genetics Group (UKCGG), CanGene-CanVar, NHS England Genomic Laboratory Hub (GLH) Haematological Malignancies Working Group and the British Society of Blood and Marrow Transplantation and cellular therapy (BSBMTCT).
Clark A; Thomas S; Hamblin A; Talley P; Kulasekararaj A; Grinfeld J; Speight B; Snape K; McVeigh TP; Snowden JA
Br J Haematol; 2023 Apr; 201(1):35-44. PubMed ID: 36786081
[TBL] [Abstract][Full Text] [Related]
2. Germline predisposition to haematological malignancies: Best practice consensus guidelines from the UK Cancer Genetics Group (UKCGG), CanGene-CanVar and the NHS England Haematological Oncology Working Group.
Speight B; Hanson H; Turnbull C; Hardy S; Drummond J; Khorashad J; Wragg C; Page P; Parkin NW; Rio-Machin A; Fitzgibbon J; Kulasekararaj AG; Hamblin A; Talley P; McVeigh TP; Snape K;
Br J Haematol; 2023 Apr; 201(1):25-34. PubMed ID: 36744544
[TBL] [Abstract][Full Text] [Related]
3. Co-design of patient information leaflets for germline predisposition to cancer: recommendations for clinical practice from the UK Cancer Genetics Group (UKCGG), Cancer Research UK (CRUK) funded CanGene-CanVar Programme and the Association of Genetic Nurse Counsellors (AGNC).
Kohut K; Speight B; Young J; Way R; Wiggins J; Monje-Garcia L; Eccles DM; Foster C; Turner L; Snape K; Hanson H; ;
J Med Genet; 2024 Jan; 61(2):142-149. PubMed ID: 38050080
[TBL] [Abstract][Full Text] [Related]
4. Germline predisposition in myeloid neoplasms: Unique genetic and clinical features of GATA2 deficiency and SAMD9/SAMD9L syndromes.
Sahoo SS; Kozyra EJ; Wlodarski MW
Best Pract Res Clin Haematol; 2020 Sep; 33(3):101197. PubMed ID: 33038986
[TBL] [Abstract][Full Text] [Related]
5. [Management of genetic predisposition to hematologic malignancies in patients undergoing allogeneic hematopoietic cell transplantation (HCT): Guidelines from the SFGM-TC].
Coiteux V; Fenwarth L; Duployez N; Ainaoui M; Borel C; Polomeni A; Yakoub-Agha I; Chalandon Y
Bull Cancer; 2023 Feb; 110(2S):S13-S29. PubMed ID: 36307324
[TBL] [Abstract][Full Text] [Related]
6. Hereditary Predisposition to Hematopoietic Neoplasms: When Bloodline Matters for Blood Cancers.
Mangaonkar AA; Patnaik MM
Mayo Clin Proc; 2020 Jul; 95(7):1482-1498. PubMed ID: 32571604
[TBL] [Abstract][Full Text] [Related]
7. The International Consensus Classification (ICC) of hematologic neoplasms with germline predisposition, pediatric myelodysplastic syndrome, and juvenile myelomonocytic leukemia.
Rudelius M; Weinberg OK; Niemeyer CM; Shimamura A; Calvo KR
Virchows Arch; 2023 Jan; 482(1):113-130. PubMed ID: 36445482
[TBL] [Abstract][Full Text] [Related]
8. Inherited thrombocytopenia and platelet disorders with germline predisposition to myeloid neoplasia.
Galera P; Dulau-Florea A; Calvo KR
Int J Lab Hematol; 2019 May; 41 Suppl 1():131-141. PubMed ID: 31069978
[TBL] [Abstract][Full Text] [Related]
9. Germline Predisposition to Myeloid Neoplasms: Diagnostic Concepts and Classifications.
Obiorah IE; Upadhyaya KD; Calvo KR
Clin Lab Med; 2023 Dec; 43(4):615-638. PubMed ID: 37865507
[TBL] [Abstract][Full Text] [Related]
10. Pedigree investigation, clinical characteristics, and prognosis analysis of haematological disease patients with germline TET2 mutation.
Wu X; Deng J; Zhang N; Liu X; Zheng X; Yan T; Ye W; Gong Y
BMC Cancer; 2022 Mar; 22(1):262. PubMed ID: 35279121
[TBL] [Abstract][Full Text] [Related]
11. Incidental detection of germline variants of potential clinical significance by massively parallel sequencing in haematological malignancies.
Yannakou CK; Jones K; Ryland GL; Thompson ER; Reid G; McBean M; Trainer A; Westerman D; Blombery P
J Clin Pathol; 2018 Jan; 71(1):84-87. PubMed ID: 28801348
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the pathogenic potential of germline DDX41 variants in hematopoietic neoplasms using the ACMG/AMP guidelines.
Matsui H; Hirata M
Int J Hematol; 2024 May; 119(5):552-563. PubMed ID: 38492200
[TBL] [Abstract][Full Text] [Related]
13. Germline Variants and Characteristic Features of Hereditary Hematological Malignancy Syndrome.
Arai H; Matsui H; Chi S; Utsu Y; Masuda S; Aotsuka N; Minami Y
Int J Mol Sci; 2024 Jan; 25(1):. PubMed ID: 38203823
[TBL] [Abstract][Full Text] [Related]
14. UK consensus recommendations for clinical management of cancer risk for women with germline pathogenic variants in cancer predisposition genes:
Hanson H; Kulkarni A; Loong L; Kavanaugh G; Torr B; Allen S; Ahmed M; Antoniou AC; Cleaver R; Dabir T; Evans DG; Golightly E; Jewell R; Kohut K; Manchanda R; Murray A; Murray J; Ong KR; Rosenthal AN; Woodward ER; Eccles DM; Turnbull C; Tischkowitz M; ; Lalloo F
J Med Genet; 2023 May; 60(5):417-429. PubMed ID: 36411032
[TBL] [Abstract][Full Text] [Related]
15. Spectrum of hematological malignancies, clonal evolution and outcomes in 144 Mayo Clinic patients with germline predisposition syndromes.
Martin ES; Ferrer A; Mangaonkar AA; Khan SP; Kohorst MA; Joshi AY; Hogan WJ; Olteanu H; Moyer AM; Al-Kali A; Tefferi A; Chen D; Wudhikarn K; Go R; Viswanatha D; He R; Ketterling R; Nguyen PL; Oliveira JL; Gangat N; Lasho T; Patnaik MM
Am J Hematol; 2021 Nov; 96(11):1450-1460. PubMed ID: 34390506
[TBL] [Abstract][Full Text] [Related]
16. Approach Toward Germline Predisposition Syndromes in Patients with Hematologic Malignancies.
Atluri H; Gerstein YS; DiNardo CD
Curr Hematol Malig Rep; 2022 Dec; 17(6):275-285. PubMed ID: 36279069
[TBL] [Abstract][Full Text] [Related]
17. Prognostic tumor sequencing panels frequently identify germ line variants associated with hereditary hematopoietic malignancies.
Drazer MW; Kadri S; Sukhanova M; Patil SA; West AH; Feurstein S; Calderon DA; Jones MF; Weipert CM; Daugherty CK; Ceballos-López AA; Raca G; Lingen MW; Li Z; Segal JP; Churpek JE; Godley LA
Blood Adv; 2018 Jan; 2(2):146-150. PubMed ID: 29365323
[TBL] [Abstract][Full Text] [Related]
18. Germline predisposition to hematopoietic malignancies.
Feurstein S; Drazer M; Godley LA
Hum Mol Genet; 2021 Oct; 30(20):R225-R235. PubMed ID: 34100074
[TBL] [Abstract][Full Text] [Related]
19. Somatic mutational landscape of hereditary hematopoietic malignancies caused by germline variants in RUNX1, GATA2, and DDX41.
Homan CC; Drazer MW; Yu K; Lawrence DM; Feng J; Arriola-Martinez L; Pozsgai MJ; McNeely KE; Ha T; Venugopal P; Arts P; King-Smith SL; Cheah J; Armstrong M; Wang P; Bödör C; Cantor AB; Cazzola M; Degelman E; DiNardo CD; Duployez N; Favier R; Fröhling S; Rio-Machin A; Klco JM; Krämer A; Kurokawa M; Lee J; Malcovati L; Morgan NV; Natsoulis G; Owen C; Patel KP; Preudhomme C; Raslova H; Rienhoff H; Ripperger T; Schulte R; Tawana K; Velloso E; Yan B; Kim E; Sood R; Hsu AP; Holland SM; Phillips K; Poplawski NK; Babic M; Wei AH; Forsyth C; Mar Fan H; Lewis ID; Cooney J; Susman R; Fox LC; Blombery P; Singhal D; Hiwase D; Phipson B; Schreiber AW; Hahn CN; Scott HS; Liu P; Godley LA; Brown AL;
Blood Adv; 2023 Oct; 7(20):6092-6107. PubMed ID: 37406166
[TBL] [Abstract][Full Text] [Related]
20. How I diagnose myeloid neoplasms with germline predisposition.
Patel N; Calvo KR
Am J Clin Pathol; 2023 Oct; 160(4):352-364. PubMed ID: 37458302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]